News Focus
News Focus
Post# of 257257
Next 10
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 185527

Tuesday, 01/05/2016 6:12:10 PM

Tuesday, January 05, 2016 6:12:10 PM

Post# of 257257
GILD—Simtuzumab phase-2 in IPF stopped for futility:

http://finance.yahoo.com/news/gilead-terminates-phase-2-study-230000133.html

Phase-2 Simtuzumab trials in NASH and PSC are unaffected by this decision.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now